The global Cluster of Differentiation (CD) Antigen Cancer Therapy Industry is experiencing dynamic expansion, underpinned by significant breakthroughs in oncology and the burgeoning adoption of targeted immunotherapy approaches. CD antigens, which are surface molecules on immune and cancer cells, serve as crucial biomarkers and therapeutic targets for a wide range of malignancies....